HomeCompareLMLLF vs CL

LMLLF vs CL: Dividend Comparison 2026

LMLLF yields 26315.79% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LMLLF wins by $802085897127229390848.00M in total portfolio value
10 years
LMLLF
LMLLF
● Live price
26315.79%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$802085897127229390848.00M
Annual income
$796,134,651,160,688,600,000,000,000.00
Full LMLLF calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — LMLLF vs CL

📍 LMLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLMLLFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LMLLF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LMLLF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LMLLF
Annual income on $10K today (after 15% tax)
$2,236,842.11/yr
After 10yr DRIP, annual income (after tax)
$676,714,453,486,585,300,000,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, LMLLF beats the other by $676,714,453,486,585,300,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LMLLF + CL for your $10,000?

LMLLF: 50%CL: 50%
100% CL50/50100% LMLLF
Portfolio after 10yr
$401042948563614695424.00M
Annual income
$398,067,325,580,344,300,000,000,000.00/yr
Blended yield
99.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

LMLLF
No analyst data
Altman Z
-103.8
Piotroski
1/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LMLLF buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLMLLFCL
Forward yield26315.79%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$802085897127229390848.00M$41.0K
Annual income after 10y$796,134,651,160,688,600,000,000,000.00$5,451.69
Total dividends collected$801694023521105215488.00M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LMLLF vs CL ($10,000, DRIP)

YearLMLLF PortfolioLMLLF Income/yrCL PortfolioCL Income/yrGap
1← crossover$2,642,279$2,631,578.95$11,014$313.84+$2.63MLMLLF
2$652,674,496$649,847,257.10$12,200$415.44+$652.66MLMLLF
3$150,717,093,655$150,018,731,944.79$13,607$553.09+$150717.08MLMLLF
4$32,537,594,543,311$32,376,327,253,099.92$15,301$741.41+$32537594.53MLMLLF
5$6,567,124,460,012,792$6,532,309,233,851,450.00$17,374$1,002.00+$6567124460.00MLMLLF
6$1,239,202,870,261,231,900$1,232,176,047,089,018,000.00$19,958$1,367.44+$1239202870261.21MLMLLF
7$218,624,156,631,620,120,000$217,298,209,560,440,600,000.00$23,243$1,887.87+$218624156631620.09MLMLLF
8$36,062,384,982,353,154,000,000$35,828,457,134,757,322,000,000.00$27,512$2,642.43+$36062384982353152.00MLMLLF
9$5,561,912,118,262,444,000,000,000$5,523,325,366,331,326,000,000,000.00$33,197$3,759.22+$5561912118262444032.00MLMLLF
10$802,085,897,127,229,400,000,000,000$796,134,651,160,688,600,000,000,000.00$40,973$5,451.69+$802085897127229390848.00MLMLLF

LMLLF vs CL: Complete Analysis 2026

LMLLFStock

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.

Full LMLLF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this LMLLF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LMLLF vs SCHDLMLLF vs JEPILMLLF vs OLMLLF vs KOLMLLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.